CD4 and infection: Our studies demonstrate that LdCen−/− infection suppresses miR-21 expression, enables IL12 mediated induction of adaptive immunity including proliferation of antigen experienced CD4+ T cells and development of a Th1 immunity, and suggest that miR-21 could be an important biomarker for LdCen−/− vaccine immunity in human clinical trials.